Advertisement
Advertisement
U.S. Markets open in 2 hrs 14 mins
Advertisement
Advertisement
Advertisement
Advertisement

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.48000.0000 (0.00%)
At close: 03:59PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/25/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.5900
52 Week Low 30.4300
50-Day Moving Average 30.8110
200-Day Moving Average 31.4410

Share Statistics

Avg Vol (3 month) 31.77M
Avg Vol (10 day) 31.15M
Shares Outstanding 5227.13M
Implied Shares Outstanding 6N/A
Float 8188.18M
% Held by Insiders 16.77%
% Held by Institutions 122.75%
Shares Short (Dec 14, 2021) 420.41M
Short Ratio (Dec 14, 2021) 48.28
Short % of Float (Dec 14, 2021) 49.09%
Short % of Shares Outstanding (Dec 14, 2021) 48.99%
Shares Short (prior month Nov 14, 2021) 420.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Jul 31, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.15%
Return on Equity (ttm)-110.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.13M
Net Income Avi to Common (ttm)-15.47M
Diluted EPS (ttm)-0.0790
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.12M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)998k
Total Debt/Equity (mrq)5.78
Current Ratio (mrq)7.95
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-13.27M
Levered Free Cash Flow (ttm)-7.39M
Advertisement
Advertisement